Jinan Ma

629 total citations
43 papers, 397 citations indexed

About

Jinan Ma is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jinan Ma has authored 43 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Jinan Ma's work include Lung Cancer Research Studies (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Inflammatory Biomarkers in Disease Prognosis (6 papers). Jinan Ma is often cited by papers focused on Lung Cancer Research Studies (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Inflammatory Biomarkers in Disease Prognosis (6 papers). Jinan Ma collaborates with scholars based in China, United States and Italy. Jinan Ma's co-authors include Chunhong Hu, Tao Hou, Fangwen Zou, Shun Jiang, Yapeng Wang, Wenhao Luo, Haixia Zhang, Fang Ma, Yuhua Feng and Yeqian Feng and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Jinan Ma

38 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinan Ma China 12 174 143 111 101 42 43 397
Chukwuemeka Ikpeazu United States 9 189 1.1× 119 0.8× 65 0.6× 144 1.4× 42 1.0× 23 356
Manali Rupji United States 13 165 0.9× 186 1.3× 76 0.7× 111 1.1× 65 1.5× 45 479
Güzin Demirağ Türkiye 10 295 1.7× 108 0.8× 124 1.1× 95 0.9× 56 1.3× 29 441
Yoojoo Lim South Korea 14 201 1.2× 162 1.1× 127 1.1× 117 1.2× 36 0.9× 56 485
Zhaofei Pang China 14 259 1.5× 152 1.1× 127 1.1× 169 1.7× 62 1.5× 29 506
Emma Zattarin Italy 11 291 1.7× 114 0.8× 120 1.1× 174 1.7× 68 1.6× 41 500
Dušica Gavrilović Serbia 13 185 1.1× 72 0.5× 70 0.6× 91 0.9× 70 1.7× 54 352
Bruna Pellini United States 14 254 1.5× 119 0.8× 192 1.7× 261 2.6× 60 1.4× 40 489
Ikuo Kamiyama Japan 10 187 1.1× 81 0.6× 74 0.7× 193 1.9× 48 1.1× 29 413
Marko Buta Serbia 12 143 0.8× 161 1.1× 108 1.0× 143 1.4× 139 3.3× 42 489

Countries citing papers authored by Jinan Ma

Since Specialization
Citations

This map shows the geographic impact of Jinan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinan Ma more than expected).

Fields of papers citing papers by Jinan Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinan Ma. The network helps show where Jinan Ma may publish in the future.

Co-authorship network of co-authors of Jinan Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Jinan Ma. A scholar is included among the top collaborators of Jinan Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinan Ma. Jinan Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhu, et al.. (2025). Unveiling the reasons for corrosion resistance difference between two phases of the Fe40Cr40Ni20 duplex MEA in the transpassive region. Corrosion Science. 257. 113277–113277. 1 indexed citations
2.
Quan, Yi, et al.. (2025). Prevalence and independent predictors of unruptured intracranial Aneurysms: A systematic review and meta-analysis. Journal of Clinical Neuroscience. 140. 111542–111542.
3.
Yh, Li, et al.. (2025). EGFR-TKI combination treatment for NSCLC with EGFR-sensitive mutation. Expert Review of Anticancer Therapy. 25(9). 1045–1056. 1 indexed citations
4.
Huang, Jianliang, Jingyi Huang, Chengyou Li, et al.. (2024). ALDH2 attenuates radiation-induced lung injury by inhibiting ROS and epithelial-mesenchymal transition mediated by the TGF-β1/Smad pathway. Pulmonary Pharmacology & Therapeutics. 87. 102334–102334. 3 indexed citations
5.
6.
7.
Ma, Jinan, et al.. (2023). Antitumor regimens with gemcitabine are safe for tumor patients with COVID-19.. Journal of Clinical Oncology. 41(16_suppl). e18064–e18064.
8.
Xiong, Hui, et al.. (2023). Washing solution of tissue biopsy compared with paraffin-embedded tissue for NSCLC gene test.. Journal of Clinical Oncology. 41(16_suppl). e21104–e21104.
9.
Wang, Sisi, Yuhua Feng, Yangchun Xie, et al.. (2022). High fibrinogen-albumin ratio index (FARI) predicts poor survival in head and neck squamous cell carcinoma patients treated with surgical resection. European Archives of Oto-Rhino-Laryngology. 279(9). 4541–4548. 6 indexed citations
10.
Chen, Han, et al.. (2020). A promising treatment option for refractory male primary choriocarcinoma: report of two cases. Translational Cancer Research. 9(4). 3054–3060. 9 indexed citations
11.
12.
Feng, Yuhua, Sisi Wang, Yan He, et al.. (2020). Systemic Inflammation Response Index Is a Predictor of Poor Survival in Locally Advanced Nasopharyngeal Carcinoma: A Propensity Score Matching Study. Frontiers in Oncology. 10. 575417–575417. 35 indexed citations
13.
Guo, Lin, Hualin Cai, Dan Tang, et al.. (2019). Effect of aprepitant administration on CINV caused by cisplatin multi-day chemotherapy and pharmacokinetics of docetaxel. Cancer Chemotherapy and Pharmacology. 83(4). 727–734. 3 indexed citations
14.
Li, Qiuli, Jinan Ma, Haipeng Li, et al.. (2017). Synchronous colorectal cancer and multiple myeloma with chest wall involvement: Is this a coincidence?. Current Problems in Cancer. 41(6). 413–418. 3 indexed citations
15.
16.
Yi, Jun, et al.. (2015). Primary intratesticular rhabdomyosarcoma: A case report and literature review. Oncology Letters. 11(2). 1016–1020. 4 indexed citations
17.
Wan, Xiaomin, Liubao Peng, Jinan Ma, Gannong Chen, & Yuan‐Jian Li. (2015). Subgroup Economic Evaluation of Radiotherapy for Breast Cancer After Mastectomy. Clinical Therapeutics. 37(11). 2515–2526.e5. 8 indexed citations
18.
19.
Ma, Jinan, Chunhong Hu, Wenjuan Li, et al.. (2014). Downregulation of c-Met expression does not enhance the sensitivity of gastric cancer cell line MKN-45 to gefitinib. Molecular Medicine Reports. 11(3). 2269–2275. 6 indexed citations
20.
Zhou, Yan, et al.. (2013). Primary giant mediastinal synovial sarcoma of the neck: A case report and review of the literature. Oncology Letters. 7(1). 140–144. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chukwuemeka Ikpeazu Breakdown of academic impact, for papers by Manali Rupji Breakdown of academic impact, for papers by Güzin Demirağ Breakdown of academic impact, for papers by Yoojoo Lim Breakdown of academic impact, for papers by Zhaofei Pang Breakdown of academic impact, for papers by Emma Zattarin Breakdown of academic impact, for papers by Dušica Gavrilović Breakdown of academic impact, for papers by Bruna Pellini Breakdown of academic impact, for papers by Ikuo Kamiyama Breakdown of academic impact, for papers by Marko Buta
Rankless by CCL
2026